Bioverativ Competitors and Similar CompaniesClear all

Polyplus-transfection's competitors and similar companies include Acorda Therapeutics and Codiak Biosciences.
Polyplus-transfection
Polyplus-transfection
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
Acorda Therapeutics
Acorda Therapeutics
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
Codiak Biosciences
Codiak Biosciences
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
Founding Date
Founding Date
2002
Founding Date
1995
Founding Date
2015
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Illkirch-Graffenstaden, FR HQ
New York, US
Locations
Ardsley, US HQ
Chelsea, US
South San Francisco, US
Waltham, US
Locations
Cambridge, US HQ
Employees
Employees
1133% increase
Employees
4742% decrease
Employees
992% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
821 k
Valuation ($)
2.8 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$117.6m (FY, 2023)
Revenue (est.)
$22.9m (FY, 2021)
Net income
Net income
N/A
Net income
($252.9m) (FY, 2023)
Net income
($37.2m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 3.2m
Total funding raised
N/A
Total funding raised
$ 168.5m
For sources of this data, please see the company profile

View Company Profiles

Acorda Therapeutics
HQ
Ardsley, US
Employees
474↓ 2% decrease

Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

View company
Codiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease

Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.

View company